• Enzymatica acquires Zymetech

    Enzymatica AB in Sweden has acquired all shares in the Icelandic company Zymetech. This acquisition gives Enzymatica exclusive rights to a patent-protected enzyme, a key ingredient in its ColdZyme® Mouth Spray.

    Press release Enzymatica
  • Zymetech receives the Icelandic Innovation Award 2015

    Zymetech has been awarded the Icelandic Innovation Award 2015. The award is awarded to a company that has achieved outstanding results in creating value from innovation, research and knowledge.

  • Skin Care

    Read more
  • Medical Devices

    Read more

Marine Marvels

We are the global leader in the therapeutic application of marine-derived enzymes. Our technology of developing and manufacturing formulations containing marine-derived enzymes is called the Penzyme® technology and is at the core of our intellectual property.

Our use of cod enzymes (that we call Penzyme®) for therapeutic application is protected by a global patent. Our core and clinical research has demonstrated effectiveness of Penzyme® against a variety of skin conditions, wound healing and viral and bacterial infections.